Sessions
Lunchtime Briefing: Navigating the AI Frontier in Cell and Gene Therapy: Breaking Barriers with Innovative Technology – Accelerating Patient On-boarding and Reducing Bureaucratic Hurdles
Lunchtime Briefing: Practical Considerations for Establishing Flexible, Scalable Manufacturing
Morning Briefing: Applying Process Optimization and Process Intensification to Cell and Gene Therapy Manufacturing
Lunchtime Briefing: Navigating the AI Frontier in Cell and Gene Therapy: Breaking Barriers with Innovative Technology – Accelerating Patient On-boarding and Reducing Bureaucratic Hurdles
Welcome Address
Moderated by: Raja Sharif, Founder & Chief Executive Officer, ATMPS
Presentation: State of the industry
Malik Kaman, Partner, ZS Consulting
Presentation: Introduction & launch
Raja Sharif, Founder & CEO, ATMPS
Presentation: Live Product Demonstration
Martin Bornhauser,Professor, Head Of The Department For Hematology And Medical Oncology, University Hospital Dresden
Speaker Panel Q&A: with all session participants joined by:
Robert Jones, Vice President, Global Bioservices, Cryoport and Amandine Breton, Director MSAT & AST, Orchard Therapeutics